| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/20/2014 | US20140051709 Compositions and Methods for Treating Myotonic Dystrophy Type 1 |
| 02/20/2014 | US20140051708 Pyrazolyl-pyrimidine derivatives as kinase inhibitors |
| 02/20/2014 | US20140051702 Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis |
| 02/20/2014 | US20140051687 Substituted indole compounds having nos inhibitory activity |
| 02/20/2014 | US20140051686 3-Arylamino Pyridine Derivatives |
| 02/20/2014 | US20140051683 7-substituted indole mcl-1 inhibitors |
| 02/20/2014 | US20140051681 Mst1 kinase inhibitors and methods of their use |
| 02/20/2014 | US20140051680 Histone Deacetylase Inhibitors |
| 02/20/2014 | US20140051679 Kinase inhibitors and method of treating cancer with same |
| 02/20/2014 | US20140051675 Modulators of cellular adhesion |
| 02/20/2014 | US20140051674 New compounds |
| 02/20/2014 | US20140051673 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same |
| 02/20/2014 | US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions |
| 02/20/2014 | US20140051660 Cyclopentylpyrazoles as n-type calcium channel blockers |
| 02/20/2014 | US20140050696 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use |
| 02/20/2014 | US20140050663 Labeled A4B2 Ligands and Methods Therefor |
| 02/19/2014 | EP2698368A1 Novel pyrazole derivative |
| 02/19/2014 | EP2698367A1 Benzimidazoles for the treatment of cancer |
| 02/19/2014 | EP2697216A1 Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 02/19/2014 | EP2697215A1 Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid |
| 02/19/2014 | EP2697203A1 Mineralocorticoid receptor antagonists |
| 02/19/2014 | EP2697200A1 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators |
| 02/19/2014 | EP2697199A1 Aryl-or heteroaryl-substituted benzene compounds |
| 02/19/2014 | EP2697198A1 Substituted benzene compounds |
| 02/19/2014 | EP2697197A1 Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (rorgamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
| 02/19/2014 | EP2696683A1 Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors |
| 02/19/2014 | CN103596943A Hydantoin derivates as Kv3 inhibitors |
| 02/19/2014 | CN103596940A Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant |
| 02/19/2014 | CN103596937A 取代的苯甲酰胺衍生物 Substituted benzamide derivatives |
| 02/19/2014 | CN103596929A Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
| 02/19/2014 | CN103596928A Neprilysin inhibitors |
| 02/19/2014 | CN103596926A Fused tricyclic compounds as RAF kinase inhibitors |
| 02/19/2014 | CN103596431A 嘧啶环己基糖皮质激素受体调节剂 Pyrimidin-cyclohexyl glucocorticoid receptor modulators |
| 02/19/2014 | CN103589421A Organic electroluminescent material and preparation method thereof |
| 02/19/2014 | CN103589420A Green organic electroluminescent material and preparation method thereof |
| 02/19/2014 | CN103588755A Preparation method for neratinib |
| 02/19/2014 | CN103588754A Preparation method of imatinib |
| 02/19/2014 | CN103588718A Novel triazinedione derivatives as GABAB receptor modulators |
| 02/19/2014 | CN103588704A Inhibitors of focal adhesion kinase |
| 02/19/2014 | CN103588702A N-substituted phenyl-4-one derivatives, and preparation method and application thereof |
| 02/19/2014 | CN103588697A 2,5-disubstituted benzsulfamide compounds, preparation method thereof and applications thereof |
| 02/19/2014 | CN102718751B Pantoprazole salt crystal form and preparation method thereof |
| 02/19/2014 | CN102532101B 2-(quinoline-8-yl)benzimidazole derivative |
| 02/19/2014 | CN102372659B Indolebenzamide derivatives and medicinal applications thereof |
| 02/19/2014 | CN102344438B Crystals of quinoline derivative and preparation methods thereof |
| 02/19/2014 | CN102216284B Method for preparing a non-hydratable crystal form |
| 02/19/2014 | CN101959857B Compound for organic electroluminescent device and organic electroluminescent device using the same |
| 02/19/2014 | CN101827836B Trisubstituted 1,2,4-triazoles |
| 02/19/2014 | CN101775006B Free radical initiator and method for peptide sequencing using thereof |
| 02/19/2014 | CN101679247B Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof |
| 02/18/2014 | US8653262 CCR2 receptor antagonists and uses thereof |
| 02/18/2014 | US8653230 Monomers, oligomeric complexes, coordination polymers, and methods for their preparation and use |
| 02/18/2014 | US8653112 Substituted pyrazoles as estrogen receptor ligands |
| 02/18/2014 | US8653111 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases |
| 02/18/2014 | US8653105 Quinoline derivatives as kinase inhibitors |
| 02/18/2014 | US8653080 Methods for screening and compounds that protect against amyloid diseases |
| 02/18/2014 | US8653071 α4β2 neuronal nicotinic acetylcholine receptor ligands |
| 02/18/2014 | US8653070 Hepatitis C virus inhibitors |
| 02/18/2014 | US8653063 N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activity |
| 02/18/2014 | US8653062 Compounds as receptor modulators with therapeutic utility |
| 02/18/2014 | US8653000 Imine substituted 2,4-diaryl-pyrroline derivatives as pesticides |
| 02/18/2014 | US8652363 Compound, near-infrared absorber, and synthetic resin composition containing same |
| 02/18/2014 | CA2701594C Heterocycle phenyl amide t-type calcium channel antagonists |
| 02/18/2014 | CA2600757C Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 02/18/2014 | CA2594377C 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
| 02/18/2014 | CA2577061C Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/18/2014 | CA2563831C Monocyclic heterocycles as kinase inhibitors |
| 02/13/2014 | WO2014025978A1 Processes for the preparation of (s)-3-4-((4-(morpholinomethyl) benzyl)oxy)-1-oxoisoindolin-2-yl) piperidine-2,6-dione and pharmaceutically acceptable forms thereof |
| 02/13/2014 | WO2014025976A1 Heteroaromatic compounds as bruton's tyrosine kinase (btk) inhibitors |
| 02/13/2014 | WO2014025964A2 Salts and solid forms of (s)-3-(4-((4-morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same |
| 02/13/2014 | WO2014025942A1 Nmda receptor modulators and uses related thereto |
| 02/13/2014 | WO2014025854A1 Piperidine amide derivatives as hiv attachment inhibitors |
| 02/13/2014 | WO2014025852A1 Tricyclic alkene derivatives as hiv attachment inhibitors |
| 02/13/2014 | WO2014025808A1 Curcumin analogs |
| 02/13/2014 | WO2014025759A1 Iap antagonists |
| 02/13/2014 | WO2014024993A1 Piperazine derivative and use thereof |
| 02/13/2014 | WO2014023815A1 New antibacterial compounds |
| 02/13/2014 | WO2014023814A1 New antibacterial compounds |
| 02/13/2014 | WO2014023813A1 Alkylpyrimidine derivatives for the treatment of viral infections and further diseases |
| 02/13/2014 | WO2014023723A1 Subtituted azines as pesticides |
| 02/13/2014 | WO2014023670A1 Herbicidally active 6'-phenyl-2,2'-bipyridine-3-carboxylic acid derivatives |
| 02/13/2014 | WO2014023669A1 Herbicidally active 2'-phenyl-2,4'-bipyridine-3-carboxylic acid derivatives |
| 02/13/2014 | WO2014023531A1 Trifluoromethylpyridine carboxamides as pesticides |
| 02/13/2014 | WO2014023390A2 (aza-)isoquinolinone derivatives |
| 02/13/2014 | WO2014023367A1 Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor ror gamma |
| 02/13/2014 | US20140046068 Method of synthesizing bepotastine or benzenesulfonic acid salt thereof and intermediates used therein |
| 02/13/2014 | US20140046058 Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof |
| 02/13/2014 | US20140046057 Salts and solid forms of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same |
| 02/13/2014 | US20140046053 Neprilysin inhibitors |
| 02/13/2014 | US20140045902 New triazole compounds as potential anti-inflammatory agents |
| 02/13/2014 | US20140045901 Imidazole derivatives and preparation method and use thereof |
| 02/13/2014 | US20140045896 1,4-dihydropyridine-3,5-dicarboxylate Derivatives And Preparation And Use Thereof |
| 02/13/2014 | US20140045872 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS |
| 02/13/2014 | US20140045869 Dna-pk inhibitors |
| 02/13/2014 | US20140045862 Cycloalkane Derivatives |
| 02/13/2014 | US20140045861 Compounds for inflammation and immune-related uses |
| 02/13/2014 | US20140045855 Chroman derivatives as trpm8 inhibitors |
| 02/13/2014 | US20140045852 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines |
| 02/13/2014 | US20140045850 Inhibitors of histone deacetylase |
| 02/13/2014 | US20140045849 Pyrimidine derivatives for the treatment of viral infections |